Enzistal tab n / an kish.rastv. 20 pc

$2.67

Enzistal tab n / an kish.rastv. 20 pc

Quantity:

Description

Composition
Active substance:
Pancreatin VR-192 mg (protease activity: at least 300 units.
FIP, lipase activity: at least 6,000 U.
FIP, amylase activity: at least 4,500 IU.
FIP), 50 mg of hemicellulase, bovine bile extract 25 mg.
Excipients:
Lactose monohydrate, magnesium stearate, colloidal silicon dioxide, tsellatsefat, diethyl phthalate, sucrose, calcium carbonate, talc, gum acacia, gelatin, titanium dioxide, yellow beeswax.
Description:
White, round, biconvex tablets, sugar-coated.
Product form:
The tablets coated with enteric coating. 10 tablets in Al / Al. blister. 2, 4 or 8 blisters 10 tablets with the instruction packed in a cardboard box.
Contraindications
Hypersensitivity to the drug, acute pancreatitis, exacerbation of chronic pancreatitis, hepatic failure, hepatitis, jaundice, gallstones, gallbladder empyema, ileus, children under 6 years old, cholelithiasis.
Precautions: cystic fibrosis.
Indications
To improve digestion in people with normal function of the gastrointestinal tract in the case of errors in the diet (irregular / poor nutrition, eating fatty foods, overeating);
In case of violation of chewing function, forced prolonged immobilization, a sedentary lifestyle;
Insufficiency of exocrine pancreatic function (chronic pancreatitis, cystic fibrosis);
Chronic inflammatory and degenerative diseases of the stomach, intestine, liver, gall bladder; state after resection or irradiation of these organs accompanied by disturbances of digestion of food, flatulence, diarrhea (in combination therapy);
Preparing to X-ray and ultrasound examination of the abdominal cavity.
Interaction with other drugs
While the use of absorption Enzistalom® amplified PAS, sulfonamides, antibiotics; possible reduction of iron absorption preparations. Simultaneous use of antacids containing calcium carbonate and / or magnesium hydroxide, can reduce the effectiveness Enzistala®. Cimetidine increases the effects of the drug.
Overdose
Symptoms: hyperuricemia and giperurikuriya.
Treatment: removal of the drug, symptomatic therapy.
pharmachologic effect
Pharmacological group:
Digestive enzymatic means.
Pharmacological properties:
Combination drug action is due to components in its composition. Enzistal® has a protective shell that does not dissolve before reaching the small intestine, which protects the enzymes from the destructive action of gastric juice. Enzistal® promotes rapid and complete digestion, alleviates the symptoms arising from digestive disorders (heavy feeling and overflow, flatulence, dyspnea, due to accumulation of gas in the intestine, diarrhea). Included in the pancreatin enzymes – amylase, protease and lipase – facilitate the digestion of carbohydrates, fats and proteins that promotes their more complete absorption in the small intestine. Hemicellulase – an enzyme that promotes the splitting of fiber that improves digestive processes, reduces the formation of gas in the intestine. Bile extract choleretic effect, promotes the emulsification of fats, increases lipase activity, improves the absorption of fats and fat soluble vitamins A, D, E, K.
Pregnancy and breast-feeding
During pregnancy and lactation the drug is prescribed only if the expected benefit to the mother outweighs the potential risk to the fetus or child.
Conditions of supply of pharmacies
Without a prescription.
side effects
Allergic reactions, nausea, diarrhea, abdominal pain, reduction of the endogenous bile acid synthesis. With prolonged use at high doses may develop hyperuricosuria, increased uric acid levels in blood plasma.
In children with high doses may develop perianal irritation and irritation of the oral mucosa.
special instructions
In cystic fibrosis drug should be used with caution, because dose should be adequate to the quality and quantity of food consumed.
Storage conditions
Store at a temperature not higher than 25 C in a dry place, protected from light.
Keep out of the reach of children.
Dosing and Administration
Enzistal®prinimayut inside, not liquid, during or immediately after a meal with a small amount of liquid. Adults – 1-2 tablets three times a day.
Higher doses prescribed by the doctor.
Children older than 6 years (by a doctor) – 1 tablet 2-3 times a day.
Duration of treatment may vary from a few days (in violation of the digestive process due to errors in the diet) to several months or years (permanent replacement therapy if necessary).
Prior to X-ray or ultrasound – 2 tablets 2-3 times a day for 2-3 days before testing.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

TORRENT

There are no reviews yet.

Add your review